Despite intense investigation, detailed molecular events occurring during transmembrane signalling by the insulin receptor remain poorly understood. We have been especially interested in understanding how insulin binds to the receptor and how the binding signal is transmitted to intracellular signalling pathways. However, detailed structural analyses of the insulin receptor and its complex with insulin have not been possible using such methods as x-ray crystallography. In fact, Dodson & colleagues recently demonstrated that crystal structures of insulin depict inactive conformers. Our own studies of insulin structure and dynamics in solution suggest that a significant change in structure accompanies receptor binding (Nature, in press), and that a protein surface not present in insulin crystals is exposed during binding and buried again within the insulin-receptor complex. Experiments are proposed to test this hypothesis and determine directly which residues of insulin and the insulin receptor interact at this important protein-- protein interface, including: (1) Multi-dimensional, isotope-assisted NMR studies of selected analogues which we hypothesized exist in configurations approximating the structure of insulin at the receptor surface. (2) Residues of insulin that are thought to be buried in the complex will be substituted with benzoylphenylalanine (Bpa), a photoactivatable amino acid, for direct confirmation of insulin positions that are in contact with the receptor. (3) Bpa-insulin analogues cross-link the insulin receptor with unusually high efficiency (70-90%); cross-linked receptors will be fragmented and sequenced to determine receptor residues that are actually buried within the complex. (4) Identified residues will be mutated to confirm effects on binding and test effects on signalling; use of tryptophan for substitutions will facilitate fluorescence energy transfer experiments with dansyl-insulin analogues to further confirm proximity to the binding pocket. Results from these studies will be used to model a binding interface between insulin and the insulin receptor. These findings will dramatically improve our understanding of structural relationships between insulin and the insulin receptor and mechanisms of insulin-stimulated receptor signalling, which is of fundamental importance for understanding normal and abnormal receptor functioning in health and disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK043123-04
Application #
2142779
Study Section
Metabolism Study Section (MET)
Project Start
1992-09-30
Project End
1997-09-29
Budget Start
1995-09-30
Budget End
1996-09-29
Support Year
4
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Joslin Diabetes Center
Department
Type
DUNS #
071723084
City
Boston
State
MA
Country
United States
Zip Code
02215
Lee, Jongsoon; Miyazaki, Masaya; Romeo, Giulio R et al. (2014) Insulin receptor activation with transmembrane domain ligands. J Biol Chem 289:19769-77
Park, Sang-Youn; Jin, Wanzhu; Woo, Ju Rang et al. (2011) Crystal structures of human TBC1D1 and TBC1D4 (AS160) RabGTPase-activating protein (RabGAP) domains reveal critical elements for GLUT4 translocation. J Biol Chem 286:18130-8
Shoelson, Steven E; Goldfine, Allison B (2009) Getting away from glucose: fanning the flames of obesity-induced inflammation. Nat Med 15:373-4
Shoelson, Steven E; Herrero, Laura; Naaz, Afia (2007) Obesity, inflammation, and insulin resistance. Gastroenterology 132:2169-80
Nishi, Masahiro; Werner, Eric D; Oh, Byung-Chul et al. (2005) Kinase activation through dimerization by human SH2-B. Mol Cell Biol 25:2607-21
Duda, Karen; Chi, Young-In; Shoelson, Steven E (2004) Structural basis for HNF-4alpha activation by ligand and coactivator binding. J Biol Chem 279:23311-6
Dhe-Paganon, Sirano; Werner, Eric D; Nishi, Masahiro et al. (2004) A phenylalanine zipper mediates APS dimerization. Nat Struct Mol Biol 11:968-74
Werner, Eric D; Lee, Jongsoon; Hansen, Lone et al. (2004) Insulin resistance due to phosphorylation of insulin receptor substrate-1 at serine 302. J Biol Chem 279:35298-305
Wick, KeriLyn R; Werner, Eric D; Langlais, Paul et al. (2003) Grb10 inhibits insulin-stimulated insulin receptor substrate (IRS)-phosphatidylinositol 3-kinase/Akt signaling pathway by disrupting the association of IRS-1/IRS-2 with the insulin receptor. J Biol Chem 278:8460-7
Cai, Dongsheng; Dhe-Paganon, Sirano; Melendez, Peter A et al. (2003) Two new substrates in insulin signaling, IRS5/DOK4 and IRS6/DOK5. J Biol Chem 278:25323-30

Showing the most recent 10 out of 26 publications